Literature DB >> 10373503

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.

E Zandi1, M Karin.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10373503      PMCID: PMC84252          DOI: 10.1128/MCB.19.7.4547

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


× No keyword cloud information.
  48 in total

1.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation.

Authors:  J DiDonato; F Mercurio; C Rosette; J Wu-Li; H Suyang; S Ghosh; M Karin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

3.  CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain.

Authors:  M A Connelly; K B Marcu
Journal:  Cell Mol Biol Res       Date:  1995

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.

Authors:  Z J Chen; L Parent; T Maniatis
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

6.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

Authors:  A A Beg; D Baltimore
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

8.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

9.  Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate.

Authors:  E Zandi; Y Chen; M Karin
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

10.  N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.

Authors:  S T Whiteside; M K Ernst; O LeBail; C Laurent-Winter; N Rice; A Israël
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  75 in total

Review 1.  Cell receptors and cell signalling.

Authors:  I J Uings; S N Farrow
Journal:  Mol Pathol       Date:  2000-12

2.  The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1.

Authors:  M Furukawa; Y Zhang; J McCarville; T Ohta; Y Xiong
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 4.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 5.  NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

Authors:  Hana Algül; Guido Adler; Roland M Schmid
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.

Authors:  A Devin; Y Lin; S Yamaoka; Z Li; M Karin
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 7.  Molecular mechanisms in lymphocyte activation and growth.

Authors:  D W Ballard
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 8.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

10.  Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway.

Authors:  Roumyana D Petrova; Jamal Mahajna; Solomon P Wasser; Nili Ruimi; Cvetomir M Denchev; Sherbel Sussan; Eviatar Nevo; Abraham Z Reznick
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.